President and Chief Operating Officer
The Medicines Company
United States of America
Tony Kingsley joined The Medicines Company (MDCO) in May 2016 as President and Chief Operating Officer. Before joining MDCO, Tony was Executive Vice President, Global Commercial Operations at Biogen, where he oversaw the launch of multiple new therapies, including TECFIDERA®, the most-prescribed oral treatment for multiple sclerosis today. Prior to Biogen, he served as Senior Vice President and General Manager of the Gynecological Surgical Products business at Hologic, Inc., and as Division President, Diagnostic Products, at Cytyc Corporation. Earlier in his career, he was a Partner at McKinsey & Company focusing on the biotechnology, pharmaceutical and medical device industries. Tony received his bachelor's degree in Government from Dartmouth College and his MBA from the Harvard Graduate School of Business Administration.
Business Management and Development